Safety and efficacy of autologous humanized CD19 CAR-T cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
自体人源化CD19 CAR-T细胞疗法治疗复发/难治性B细胞非霍奇金淋巴瘤的安全性和有效性
期刊:Bone Marrow Transplantation
影响因子:5.2
doi:10.1038/s41409-025-02691-2
Dong, Yetian; Yang, Tingting; Zhao, Mengyu; Song, Fengmei; Chen, Rongrong; Zhang, Mingming; Hong, Ruimin; Feng, Jingjing; Fu, Shan; Xiao, Pingnan; Xu, Huijun; Cui, Jiazhen; Huang, Simao; Wei, Guoqing; Chang, Alex H; Huang, He; Hu, Yongxian
B细胞
T细胞
淋巴瘤
T细胞
细胞生物学
CD19
免疫/内分泌